New Drug Specifically Detects Neuroendocrine Tumors – Leading to Even More Targeted Treatments

A new drug combined with leading technology provides the OSUCCC – James neuroendocrine experts with the kind of imaging that’s just not available with standard imaging techniques. Available only at The James, the drug offers even clearer, closer and more accurate imaging for neuroendocrine tumors, enabling the physicians to have more in-depth information – and that means they can design highly personalized, targeted treatments for neuroendocrine cancer patients.